title: Comparative evaluation of Tc-99m-heat-denatured RBC and Tc-99m-anti-D IgG opsonized RBC spleen planar and SPECT scintigraphy in the detection of accessory spleen in postsplenectomy patients with chronic idiopathic thrombocytopenic purpura.
abstract: OBJECTIVE
  Radionuclide imaging specific for functioning splenic tissue is considered the method of choice to detect an accessory spleen in patients of chronic idiopathic thrombocytopenia purpura (ITP), who present with relapse after splenectomy. Radioimmunospleen scintigraphy with Tc-99m-labeled autologous RBC opsonized with anti-D IgG (RIS) is claimed to be more sensitive and specific than Tc-99m heat-denatured RBC spleen scintigraphy (HDRS) in the detection of an accessory spleen. We compared the efficacy of RIS with HDRBC for the detection of accessory spleens
  
  
  METHODS
  A total of 45 patients (male:female = 17:28, age range: 6-58 years) who presented with relapse of ITP after splenectomy underwent scintigraphy with both methods. An average of 3 years had passed since surgery. All patients were imaged by a dual-head gamma camera with high-resolution collimators; planar static images and SPECT of abdomen were acquired.
  
  
  RESULTS
  Accessory spleens were detected in 31% (14 of 45) of patients, 6 had 1 each and 8 had more than 1 (including 1 patient who had 13 accessory spleens). Both methods were concordant in all the patients. There was no difference in the scintigraphic picture (planar and SPECT) or in the size and number of accessory spleens detected.
  
  
  CONCLUSIONS
  Tc-99m-labeled anti-D IgG opsonized autologous RBC spleen scintigraphy provides no additional diagnostic information over heat-denatured RBC spleen scintigraphy. Heat-denatured RBC scintigraphy thus remains the procedure of choice in the detection of accessory spleens.
authors.affiliation: Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Hentok
authors.initials: H
authors.lastname: Phom
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: M
authors.initials: M
authors.lastname: Tripathi
authors.forename: N
authors.initials: N
authors.lastname: Chandrashekar
authors.forename: V P
authors.initials: VP
authors.lastname: Choudhry
authors.forename: A
authors.initials: A
authors.lastname: Malhotra
authors.forename: C S
authors.initials: CS
authors.lastname: Bal
mesh_terms: D000293:Adolescent; D000328:Adult; D016009:Chi-Square Distribution; D002648:Child; D002908:Chronic Disease; D004912:Erythrocytes; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007518:Isoantibodies / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000000981:diagnostic imaging* / Q000601:surgery; D016719:Radioimmunodetection; D019275:Radiopharmaceuticals; D012204:Rh-Hr Blood-Group System / Q000276:immunology; D018029:Rho(D) Immune Globulin; D013670:Sodium Pertechnetate Tc 99m; D013154:Spleen / Q000002:abnormalities* / Q000000981:diagnostic imaging; D013156:Splenectomy; D018709:Statistics, Nonparametric; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D007074:Immunoglobulin G; D007518:Isoantibodies; C061961:RHO(D) antibody; D019275:Radiopharmaceuticals; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin; D013670:Sodium Pertechnetate Tc 99m